BETH ISRAEL DEACONESS MEDICAL CENTER
- Country
- πΊπΈUnited States
- Ownership
- -
- Established
- 1896-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.bidmc.org/
Effect of Standardized Consent for Urogynecological Procedures on Patient Satisfaction
- Conditions
- Pelvic Organ ProlapseUrinary Incontinence
- Interventions
- Other: Standardized visual presentation
- First Posted Date
- 2014-12-10
- Last Posted Date
- 2018-12-06
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 64
- Registration Number
- NCT02313701
- Locations
- πΊπΈ
BIDMC, Boston, Massachusetts, United States
Non-invasive Measurement of Brain Oxygen Levels in People With Subthalamic Deep Brain Stimulators
- Conditions
- Parkinson's Disease
- Interventions
- Other: Deep brain stimulator
- First Posted Date
- 2014-10-30
- Last Posted Date
- 2017-05-08
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 8
- Registration Number
- NCT02278406
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Comparison of Contrast-enhanced Spectral Mammography (CESM) to MRI in Screening High Risk Women for Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- Other: MRIOther: CESM
- First Posted Date
- 2014-10-27
- Last Posted Date
- 2020-03-16
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 44
- Registration Number
- NCT02275871
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Assessment of the Use of Ultrasound for Epidural Catheter Placement and Comparison With Palpation Technique
- Conditions
- Labor Pain
- Interventions
- Device: ultrasound guidanceDevice: palpation guidance
- First Posted Date
- 2014-10-22
- Last Posted Date
- 2024-05-07
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 110
- Registration Number
- NCT02271100
- Locations
- πΊπΈ
Beth Isreal Deaconess Medical Center, Boston, Massachusetts, United States
Preventing the Inflammatory Response to Experimentally-induced Insomnia Symptoms
- First Posted Date
- 2014-10-20
- Last Posted Date
- 2017-03-15
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 8
- Registration Number
- NCT02268565
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Challenging the Inflammatory Response System in Insomnia Disorder
- Conditions
- Insomnia
- Interventions
- Behavioral: Cold Pressor Test
- First Posted Date
- 2014-10-10
- Last Posted Date
- 2019-07-22
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 44
- Registration Number
- NCT02261597
- Locations
- πΊπΈ
BIDMC, Boston, Massachusetts, United States
Stepping Up for Safety: Improving Teamwork at the Planned Parenthood Affiliates Through the TeamSTEPPS Model
- Conditions
- Improving Team Work at the Planned Parenthood Affiliates
- Interventions
- Behavioral: Team training using the TeamSTEPPS model
- First Posted Date
- 2014-10-09
- Last Posted Date
- 2020-11-24
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT02260245
Neuromuscular Blockade for Post-Cardiac Arrest Care
- First Posted Date
- 2014-10-09
- Last Posted Date
- 2021-01-29
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 83
- Registration Number
- NCT02260258
- Locations
- πΊπΈ
Brigham and Women's Hospital, Boston, Massachusetts, United States
πΊπΈBeth Israel Deaconess Medical Center, Boston, Massachusetts, United States
πΊπΈRobert Swor, Royal Oak, Michigan, United States
Evaluation of the PelvicSim Simulator for Training in Intrauterine Device Insertions
- Conditions
- Contraceptive Devices, IntrauterineEducation, Medical
- Interventions
- Device: Manufacturer modelOther: PelvicSim
- First Posted Date
- 2014-08-19
- Last Posted Date
- 2017-05-24
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT02220205
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Conditions
- Acute Myeloid Leukemia, in RelapseRecurrent Adult Acute Myeloid Leukemia
- Interventions
- First Posted Date
- 2014-07-30
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 33
- Registration Number
- NCT02204085
- Locations
- πΊπΈ
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
πΊπΈBeth Israel Deaconess Medical Center, Boston, Massachusetts, United States